ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report

ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cureus 2023, Vol.15 (3), p.e36711-e36711
Hauptverfasser: Takayasu, Hirokazu, Kata, Yuki, Otsu, Yukiko, Inoue, Satoshi, Kaneko, Takeshi
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e36711
container_issue 3
container_start_page e36711
container_title Cureus
container_volume 15
creator Takayasu, Hirokazu
Kata, Yuki
Otsu, Yukiko
Inoue, Satoshi
Kaneko, Takeshi
description
doi_str_mv 10.7759/cureus.36711
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2807914256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2807914256</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_28079142563</originalsourceid><addsrcrecordid>eNqVjM9OAjEYxBujCUS58QA9enCxLbBdvK0NhEQ0ZCXhSD7Lp9bsttg_Fx-Bp7YhHLx6mplfZoaQIWcjKaeze508pjAal5LzC9IXvKyKileTyz--RwYhfDHGOJOCSdYnx3r1VDQI3oP9wD19eVUrRbcmflLlrHadiWAjXc4bUTynk3_0CCFSBVajp2uIBjPdZBrzwWlat6ijsebtLvNcTj-pgxzA7uka_Tk_0Dq_BKQNHpyPN-TqHdqAg7Nek9vFfKOWxcG774Qh7joTNLYtWHQp7ETF5IxPxLQc_6P6C5nBXVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2807914256</pqid></control><display><type>report</type><title>ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Takayasu, Hirokazu ; Kata, Yuki ; Otsu, Yukiko ; Inoue, Satoshi ; Kaneko, Takeshi</creator><creatorcontrib>Takayasu, Hirokazu ; Kata, Yuki ; Otsu, Yukiko ; Inoue, Satoshi ; Kaneko, Takeshi</creatorcontrib><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.36711</identifier><language>eng</language><ispartof>Cureus, 2023, Vol.15 (3), p.e36711-e36711</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>782,786,4494,27934</link.rule.ids></links><search><creatorcontrib>Takayasu, Hirokazu</creatorcontrib><creatorcontrib>Kata, Yuki</creatorcontrib><creatorcontrib>Otsu, Yukiko</creatorcontrib><creatorcontrib>Inoue, Satoshi</creatorcontrib><creatorcontrib>Kaneko, Takeshi</creatorcontrib><title>ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report</title><title>Cureus</title><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2023</creationdate><recordtype>report</recordtype><recordid>eNqVjM9OAjEYxBujCUS58QA9enCxLbBdvK0NhEQ0ZCXhSD7Lp9bsttg_Fx-Bp7YhHLx6mplfZoaQIWcjKaeze508pjAal5LzC9IXvKyKileTyz--RwYhfDHGOJOCSdYnx3r1VDQI3oP9wD19eVUrRbcmflLlrHadiWAjXc4bUTynk3_0CCFSBVajp2uIBjPdZBrzwWlat6ijsebtLvNcTj-pgxzA7uka_Tk_0Dq_BKQNHpyPN-TqHdqAg7Nek9vFfKOWxcG774Qh7joTNLYtWHQp7ETF5IxPxLQc_6P6C5nBXVg</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Takayasu, Hirokazu</creator><creator>Kata, Yuki</creator><creator>Otsu, Yukiko</creator><creator>Inoue, Satoshi</creator><creator>Kaneko, Takeshi</creator><scope>7X8</scope></search><sort><creationdate>20230301</creationdate><title>ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report</title><author>Takayasu, Hirokazu ; Kata, Yuki ; Otsu, Yukiko ; Inoue, Satoshi ; Kaneko, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_28079142563</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Takayasu, Hirokazu</creatorcontrib><creatorcontrib>Kata, Yuki</creatorcontrib><creatorcontrib>Otsu, Yukiko</creatorcontrib><creatorcontrib>Inoue, Satoshi</creatorcontrib><creatorcontrib>Kaneko, Takeshi</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takayasu, Hirokazu</au><au>Kata, Yuki</au><au>Otsu, Yukiko</au><au>Inoue, Satoshi</au><au>Kaneko, Takeshi</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report</atitle><jtitle>Cureus</jtitle><date>2023-03-01</date><risdate>2023</risdate><volume>15</volume><issue>3</issue><spage>e36711</spage><epage>e36711</epage><pages>e36711-e36711</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><doi>10.7759/cureus.36711</doi></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Cureus, 2023, Vol.15 (3), p.e36711-e36711
issn 2168-8184
2168-8184
language eng
recordid cdi_proquest_miscellaneous_2807914256
source PubMed Central; PubMed Central Open Access
title ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T13%3A36%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=ALK-Rearranged%20NSCLC%20With%20Concomitant%20HER2-Mutant%20Breast%20Cancer%20Patient%20Treated%20With%20Alectinib,%20Trastuzumab,%20and%20Pertuzumab:%20A%20Case%20Report&rft.jtitle=Cureus&rft.au=Takayasu,%20Hirokazu&rft.date=2023-03-01&rft.volume=15&rft.issue=3&rft.spage=e36711&rft.epage=e36711&rft.pages=e36711-e36711&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.36711&rft_dat=%3Cproquest%3E2807914256%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2807914256&rft_id=info:pmid/&rfr_iscdi=true